154 related articles for article (PubMed ID: 32898940)
1. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
[TBL] [Abstract][Full Text] [Related]
2. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.
Cho J; Chen JCY; Paludo J; Conboy EE; Lanpher BC; Alberts SR; Halfdanarson TR
J Gastrointest Oncol; 2019 Jun; 10(3):582-588. PubMed ID: 31183212
[TBL] [Abstract][Full Text] [Related]
5. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
[TBL] [Abstract][Full Text] [Related]
6. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Chan JS; Harding CO; Blanke CD
South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
[TBL] [Abstract][Full Text] [Related]
7. Successful early management of a female patient with a metabolic stroke due to ornithine transcarbamylase deficiency.
Tummolo A; Favia V; Bellantuono R; Bellino V; Ranieri A; Morrone A; De Palo T; Papadia F
Pediatr Emerg Care; 2013 May; 29(5):656-8. PubMed ID: 23640148
[TBL] [Abstract][Full Text] [Related]
8. Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma.
Bartlett AL; Leslie ND; Gupta A; Geller JI
Pediatr Blood Cancer; 2018 Dec; 65(12):e27392. PubMed ID: 30094907
[TBL] [Abstract][Full Text] [Related]
9. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
[No Abstract] [Full Text] [Related]
10. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
11. Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency.
Choi DE; Lee KW; Shin YT; Na KR
J Korean Med Sci; 2012 May; 27(5):556-9. PubMed ID: 22563224
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
13. Successful continuous venovenous hemofiltration in a neonate with hyperammonemia from ornithine transcabamylase deficiency.
Pirojsakul K; Tangnararatchakit K; Vaewpanich J; Niyomvit K; Chanhom D; Udomchaisakul R; Tapaneya-Olarn W; Wattanasirichaigoon D
J Med Assoc Thai; 2013 Nov; 96(11):1512-7. PubMed ID: 24428103
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
Patt YZ; Hassan MM; Lozano RD; Brown TD; Vauthey JN; Curley SA; Ellis LM
J Clin Oncol; 2003 Feb; 21(3):421-7. PubMed ID: 12560429
[TBL] [Abstract][Full Text] [Related]
15. Intermittent hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency.
Gulati S; Menon S; Kabra M; Kalra V
Indian J Pediatr; 2004 Jul; 71(7):645-7. PubMed ID: 15280615
[TBL] [Abstract][Full Text] [Related]
16. Successful multimodal treatment for aggressive metastatic and recurrent fibrolamellar hepatocellular carcinoma in a child.
Okur A; Eser EP; Yilmaz G; Dalgiç A; Akdemir ÜÖ; Oğuz A; Karadeniz C; Akyol G; Demiroğullari B; Boyunağa Ö; Pinarli FG
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e328-32. PubMed ID: 24608073
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.
Wilson JM; Shchelochkov OA; Gallagher RC; Batshaw ML
Mol Genet Metab; 2012 Feb; 105(2):263-5. PubMed ID: 22129577
[TBL] [Abstract][Full Text] [Related]
18. Curative Treatment of Ornithine Transcarbamylase Deficiency With a Liver Transplant: A Case Report.
Shamsaeefar A; Nikeghbalian S; Dehghani SM; Kazemi K; Motazedian N; Geramizadeh B; Malekhosseini SA
Exp Clin Transplant; 2019 Feb; 17(1):119-120. PubMed ID: 27447480
[TBL] [Abstract][Full Text] [Related]
19. Continuous arteriovenous hemodiafiltration in the acute treatment of hyperammonaemia due to ornithine transcarbamylase deficiency.
Chen CY; Chen YC; Fang JT; Huang CC
Ren Fail; 2000 Nov; 22(6):823-36. PubMed ID: 11104170
[TBL] [Abstract][Full Text] [Related]
20. Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency.
Kazmierski D; Sharma N; O'Leary K; Ochieng P
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34035022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
